GLENMARK PHARMACEUTICALS LTD. - Press Release

Sub:- Glenmark Pharmaceuticals to Initiate Clinical Study for GBR 1342, Second Investigational New Drug from Immuno-Oncology Portfolio With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.